Cargando…

Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination

After eliminating local malaria transmission and being certified as a malaria-free country, Sri Lanka is facing the challenge of imported malaria. At the same time, the country has the unique opportunity to be a case study for other countries in a similar situation by approaching this issue systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dharmawardena, Priyani, Rodrigo, Chaturaka, Mendis, Kamini, de A. W. Gunasekera, W. M. Kumudu T., Premaratne, Risintha, Ringwald, Pascal, Fernando, Deepika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705151/
https://www.ncbi.nlm.nih.gov/pubmed/29182619
http://dx.doi.org/10.1371/journal.pone.0188613
_version_ 1783282010700120064
author Dharmawardena, Priyani
Rodrigo, Chaturaka
Mendis, Kamini
de A. W. Gunasekera, W. M. Kumudu T.
Premaratne, Risintha
Ringwald, Pascal
Fernando, Deepika
author_facet Dharmawardena, Priyani
Rodrigo, Chaturaka
Mendis, Kamini
de A. W. Gunasekera, W. M. Kumudu T.
Premaratne, Risintha
Ringwald, Pascal
Fernando, Deepika
author_sort Dharmawardena, Priyani
collection PubMed
description After eliminating local malaria transmission and being certified as a malaria-free country, Sri Lanka is facing the challenge of imported malaria. At the same time, the country has the unique opportunity to be a case study for other countries in a similar situation by approaching this issue systematically, guided by evidence. This study demonstrates the importance of developing a mechanism to detect imported malaria and adopting an evidence-based approach to study the resistance of imported malaria to anti-malarial medicines. This is a prospective study of patients diagnosed with imported malaria in Sri Lanka and treated according to the national treatment guidelines, over 24 months (2015/2016). The clinical features, time to diagnosis, origin of the infection, infecting species, parasite density and the treatment given were recorded. All patients were followed up for 28 days, and in the case of Plasmodium vivax and P. ovale infections, the follow up period was extended to 12 months to establish treatment failures and relapses. Fifty nine uncomplicated and 15 severe imported malaria cases were reported in Sri Lanka during the study period. Most of these infections originated in either Sub-Saharan Africa or South and Southeast Asia. Having a P. vivax infection and low parasitic counts were significantly associated with relative diagnostic delay. One of the 14 uncomplicated P. falciparum patients and two of the 12 severe P. falciparum malaria patients who were followed up till day 28 had a late clinical failure. The others responded adequately to treatment both clinically and parasitologically. There was no treatment failure reported amongst any other species. This study, which is the first to assess the therapeutic response of imported malaria in Sri Lanka after elimination, demonstrates that the current antimalarial treatment policies and strategies in Sri Lanka have been effective against infections acquired overseas up until the end of year 2016.
format Online
Article
Text
id pubmed-5705151
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57051512017-12-08 Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination Dharmawardena, Priyani Rodrigo, Chaturaka Mendis, Kamini de A. W. Gunasekera, W. M. Kumudu T. Premaratne, Risintha Ringwald, Pascal Fernando, Deepika PLoS One Research Article After eliminating local malaria transmission and being certified as a malaria-free country, Sri Lanka is facing the challenge of imported malaria. At the same time, the country has the unique opportunity to be a case study for other countries in a similar situation by approaching this issue systematically, guided by evidence. This study demonstrates the importance of developing a mechanism to detect imported malaria and adopting an evidence-based approach to study the resistance of imported malaria to anti-malarial medicines. This is a prospective study of patients diagnosed with imported malaria in Sri Lanka and treated according to the national treatment guidelines, over 24 months (2015/2016). The clinical features, time to diagnosis, origin of the infection, infecting species, parasite density and the treatment given were recorded. All patients were followed up for 28 days, and in the case of Plasmodium vivax and P. ovale infections, the follow up period was extended to 12 months to establish treatment failures and relapses. Fifty nine uncomplicated and 15 severe imported malaria cases were reported in Sri Lanka during the study period. Most of these infections originated in either Sub-Saharan Africa or South and Southeast Asia. Having a P. vivax infection and low parasitic counts were significantly associated with relative diagnostic delay. One of the 14 uncomplicated P. falciparum patients and two of the 12 severe P. falciparum malaria patients who were followed up till day 28 had a late clinical failure. The others responded adequately to treatment both clinically and parasitologically. There was no treatment failure reported amongst any other species. This study, which is the first to assess the therapeutic response of imported malaria in Sri Lanka after elimination, demonstrates that the current antimalarial treatment policies and strategies in Sri Lanka have been effective against infections acquired overseas up until the end of year 2016. Public Library of Science 2017-11-28 /pmc/articles/PMC5705151/ /pubmed/29182619 http://dx.doi.org/10.1371/journal.pone.0188613 Text en © 2017 Dharmawardena et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Dharmawardena, Priyani
Rodrigo, Chaturaka
Mendis, Kamini
de A. W. Gunasekera, W. M. Kumudu T.
Premaratne, Risintha
Ringwald, Pascal
Fernando, Deepika
Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination
title Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination
title_full Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination
title_fullStr Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination
title_full_unstemmed Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination
title_short Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination
title_sort response of imported malaria patients to antimalarial medicines in sri lanka following malaria elimination
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705151/
https://www.ncbi.nlm.nih.gov/pubmed/29182619
http://dx.doi.org/10.1371/journal.pone.0188613
work_keys_str_mv AT dharmawardenapriyani responseofimportedmalariapatientstoantimalarialmedicinesinsrilankafollowingmalariaelimination
AT rodrigochaturaka responseofimportedmalariapatientstoantimalarialmedicinesinsrilankafollowingmalariaelimination
AT mendiskamini responseofimportedmalariapatientstoantimalarialmedicinesinsrilankafollowingmalariaelimination
AT deawgunasekerawmkumudut responseofimportedmalariapatientstoantimalarialmedicinesinsrilankafollowingmalariaelimination
AT premaratnerisintha responseofimportedmalariapatientstoantimalarialmedicinesinsrilankafollowingmalariaelimination
AT ringwaldpascal responseofimportedmalariapatientstoantimalarialmedicinesinsrilankafollowingmalariaelimination
AT fernandodeepika responseofimportedmalariapatientstoantimalarialmedicinesinsrilankafollowingmalariaelimination